Dáil Éireann Debate, Tuesday - 12 July 2022
159. Deputy David Cullinane asked the Minister for Health the status of the reimbursement pricing negotiations for the cystic fibrosis medication kaftrio for children aged 6 to 11 years; and if he will make a statement on the matter. [37355/22]
View answer933. Deputy Neale Richmond asked the Minister for Health when the HSE will make a decision on expanding access to kaftrio for children aged 6 to 11 years with cystic fibrosis; and if he will make a statement on the matter. [37611/22]
View answerI propose to take Questions Nos. 159 and 933 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
